|
US6303321B1
(en)
|
1999-02-11 |
2001-10-16 |
North Shore-Long Island Jewish Research Institute |
Methods for diagnosing sepsis
|
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
|
US7696169B2
(en)
|
2003-06-06 |
2010-04-13 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
WO2005025604A2
(en)
*
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
|
CA2882022A1
(en)
|
2003-09-11 |
2005-03-24 |
Walter Newman |
Monoclonal antibodies against hmgb1
|
|
PL1768677T3
(pl)
*
|
2004-07-02 |
2009-01-30 |
Creabilis Therapeutics Spa |
Kwasy nukleinowe do leczenia patologii związanych z HMGB-1
|
|
WO2006012373A2
(en)
*
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Combination therapies of hmgb and complement inhibitors against inflammation
|
|
NZ553809A
(en)
*
|
2004-09-03 |
2010-03-26 |
Creabilis Therapeutics Spa |
Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1
|
|
US7585504B2
(en)
*
|
2004-10-22 |
2009-09-08 |
Medimmune, Llc |
High affinity antibodies against HMGB1 and methods of use thereof
|
|
EP1899376A2
(en)
*
|
2005-06-16 |
2008-03-19 |
The Feinstein Institute for Medical Research |
Antibodies against hmgb1 and fragments thereof
|
|
WO2007011606A2
(en)
*
|
2005-07-18 |
2007-01-25 |
Critical Therapeutics, Inc. |
USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
|
|
WO2007031100A1
(en)
*
|
2005-09-14 |
2007-03-22 |
Ostini, Marco |
Active immunotherapy of life-threatening systemic inflammation
|
|
EP1957534A1
(en)
*
|
2005-11-09 |
2008-08-20 |
Pharmexa A/S |
Therapeutic vaccines targeting hmgb1
|
|
AU2007296843C1
(en)
|
2006-09-15 |
2012-08-16 |
Creabilis Therapeutics S.P.A. |
Polymer conjugates of Box-A of HMGB1 and Box-A variants of HMGB1
|
|
PT2066339E
(pt)
|
2006-09-18 |
2014-10-31 |
Texas A & M Univ Sys |
Composições e métodos de potenciar respostas imunes
|
|
WO2008099913A1
(ja)
|
2007-02-15 |
2008-08-21 |
Kumamoto University |
ヒトhmgb-1に特異的に結合する抗体を有効成分として含有する治療剤
|
|
ES2654542T3
(es)
|
2008-04-30 |
2018-02-14 |
Genomix Co., Ltd. |
Procedimiento de recolección de células funcionales in vivo con alta eficiencia
|
|
US11191786B2
(en)
|
2009-10-28 |
2021-12-07 |
StemRIM Inc. |
Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into blood
|
|
US8956618B2
(en)
|
2010-01-21 |
2015-02-17 |
The Texas A&M University System |
Vaccine vectors and methods of enhancing immune responses
|
|
NZ604412A
(en)
|
2010-06-09 |
2015-01-30 |
Univ Arkansas |
Vaccine and methods to reduce campylobacter infection
|
|
EP2703487B1
(en)
|
2011-04-26 |
2018-06-27 |
Genomix Co., Ltd. |
Peptide for inducing regeneration of tissue and use thereof
|
|
AU2013335684B2
(en)
|
2012-10-25 |
2017-06-29 |
Osaka University |
Novel method for treating cardiac infarction using HMGB1 fragment
|
|
DK2913059T3
(en)
|
2012-10-25 |
2018-06-25 |
Genomix Co Ltd |
Hitherto UNKNOWN PROCEDURE FOR TREATMENT OF SPINE INJURY USING HMGB1 FRAGMENT
|
|
US9550825B2
(en)
|
2013-01-28 |
2017-01-24 |
Evec Inc. |
Humanized anti-HMGB1 antibody or antigen-binding fragment thereof
|
|
HUE047484T2
(hu)
|
2013-02-14 |
2020-04-28 |
Univ Arkansas |
Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására
|
|
CA2906079C
(en)
|
2013-03-15 |
2022-08-23 |
The Board Of Trustees Of The University Of Arkansas |
Compositions and methods of enhancing immune responses to enteric pathogens
|
|
KR20190015712A
(ko)
|
2016-05-03 |
2019-02-14 |
더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 |
면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법
|
|
US11969459B2
(en)
|
2017-01-27 |
2024-04-30 |
StemRIM Inc. |
Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure
|
|
AU2018236271B2
(en)
|
2017-03-15 |
2023-12-21 |
Research Institute At Nationwide Children's Hospital |
Composition and methods for disruption of bacterial biofilms without accompanying inflammation
|
|
CA3084013A1
(en)
|
2017-12-01 |
2019-06-06 |
StemRIM Inc. |
Ectodermal mesenchymal stem cells and method for producing same
|
|
WO2019107530A1
(ja)
*
|
2017-12-01 |
2019-06-06 |
株式会社ステムリム |
炎症性腸疾患の治療薬
|
|
WO2019156137A1
(ja)
*
|
2018-02-08 |
2019-08-15 |
株式会社ステムリム |
乾癬の治療薬
|
|
US12304933B2
(en)
|
2018-10-05 |
2025-05-20 |
StemRIM Inc. |
Disease treatment drug based on mesenchymal-stem-cell mobilization
|
|
SG11202103001PA
(en)
*
|
2018-10-05 |
2021-04-29 |
Res Inst Nationwide Childrens Hospital |
Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application
|
|
CN111743890A
(zh)
*
|
2019-03-26 |
2020-10-09 |
深圳先进技术研究院 |
水绫霉素或其衍生物的用途
|